Palm Coast, Florida, November 11, 2020 – OTC PR WIRE – Gold River Productions, Inc. (OTC Pink: GRPS) and Rushnet Inc. (OTC Pink: RSHN) announce progress on a number of initiatives and acquisitions in joint projects.
The Company is pleased to announce that their acquisition of an historically profitable Autistic Spectrum focused full-service school is fulfilling all needs of students. “These schools have a unique formulation to maximize the learning capacity of children afflicted with varying stages of Autistic Spectrum Disorder,” says Richard Goulding, M.D. Chairman of the Board of Gold River and Rushnet. “It’s our intention to replicate this successful schooling formula and to address the specific problems these kids have utilizing our herbal formulations that specifically target these kids’ needs. With funding, our Spectrum formulations have the capacity to improve the lives of those who suffer from Autistic Spectrum Disorder, an issue influencing, at least marginally in some cases, one out of every 59 individuals.”
RSHN and GRPS have jointly engaged the services of Products Placement Unlimited and its owner, Ronnda Shields to place products and services in multiple outlets, including a unique marketing outlet and mechanism to be further explained in the near future. “Ronnda only takes on unique products that have a strong market potential. She’s a perfect fit for our company and she’s already placed products in a number of outlets,” says Rushnet CEO, Frank DeAngelo. “Our first commercial product was released on a trial basis and the response was remarkable. We are revamping the formulation and the name to be even more powerful and effective. ‘Defender’ will be on the market shortly. Other products utilizing Ms. Shields’ unique marketing strategies are already in the works, including hi-octane CBG gummies for pain and GI issues.”
RSHN announces its initial formulations of herbal blends that address growing needs for problem areas in medicine. “Our formulations are created from the most potent portion of the plant, carefully extracted to enhance efficacy and compounded based on many years of clinical experience,” says Richard Goulding, Chairman of the Board. He further explains that, “Entities such as pain and sleep have become extremely difficult to address from a physician’s standpoint due to the growing concern of addiction and dependency fueled by opioid and other toxic medications. Our formulations are safe, non-addictive and represent stand-alone options for physicians and patients for routine and difficult, and often pervasive medical maladies, including sleep, pain, addiction and anxiety, among others.”
RSHN created a doctor-patient-herbal formulation network that facilitates ease of assumption of our herbal formulations and include education enhancement utilizing our specially focused videos created to enlighten patients and provide necessary background for physicians to enhance their practices with the products. “Essentially, this allows patients to direct purchase our doctor-recommended herbal products using their phones or computers. It also makes available video tutorials for patient and doctor for instructional purposes. The software facilitates logistics of delivery and payment obviating the need for storage of products,” says Richard Goulding, M.D. “This will help clarify when and how to use our herbal products created by RSHN and to provide literature support for the use of specific herbs,” he continues.
As a large shareholder in Stevia Nutra Corp., the Company is pleased to inform shareholders that Stevia Nutra has sold a portion of its first crop. Proceeds will be utilized towards a much larger yield in the next growing season. While the Company remains a shareholder, they are pleased at the progress that Stevia Nutra has made towards procuring preferred vendor status with the Veterans Administration, which would permit another distribution platform for the products in the near future.
GRPS and RSHN are pleased to announce trademark approval notices for Insominoplex (88482232), Painplex (88482223) and Stressplex (88482242). The Company has been in the process of securing production/manufacturing for these and other products. The Company is nearly complete with the Tier 2 Form 1A. Given the passage of time in active pursuit of government grants, the pursuit of which to date has not been successful, the Company certainly cannot be certain that we will secure such funding.
Finally, Halberd Corporation’s coronavirus initiatives continue to progress and exceed expectations. Gold River and Rushnet each enjoy a 5% net income interest in the technology.
About Able Academics:
Able Academics provides an educational and clinical behavioral health services program for children on the autism spectrum or related conditions. Its partnership with Gold River will provide the first-ever nutraceutical support system designed to improve cognitive ability, increase learning speed and afford quicker progression towards high school and even college education. The current pharmaceutical regimen often leaves the patient unresponsive and impossible to educate. It’s our goal to eliminate or greatly reduce these drugs whose side effects too often impede progress.
About Rushnet, Inc.:
Dedicated to changing people’s lives, Rushnet is a groundbreaking company aiming at improving quality of life and longevity. Our broad products and trademarked brand Herbal Therapeutics include nutraceuticals, CBD, land, education and more. With a unique staff of physicians, cultivators, and CBD experts, we are poised to tackle different disease states on an unprecedented level. Utilizing years of experience in herbals, rare cannabinoids, traditional and non-traditional methods of patient care, we are in the unique position to utilize CBD and herbals in the most effective ways possible. Emphasis on what already works, then augmenting effective formulas with high-quality cannabinoids in therapeutic levels can achieve unprecedented symptom control in a myriad of disease states.
About Gold River Productions, Inc.:
Gold River will focus on market-targeted products including, but not limited to, rare cannabinoids and effective products where a particular need is identified. Products for pain relief, sleep, etc. that will be distributed through convenience stores, independent pharmacies and more will have mass appeal to the market.
This document contains “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, which are subject to a number of risks and uncertainties, many of which are outside Gold River’s control. These include but are not limited to the impact of competitors’ products, services and pricing; product demand; market acceptance; new product development; reliance on key strategic alliances; the regulatory environment; fluctuations in operating results; and other risks which are detailed from time to time in the Company’s filings with the Securities and Exchange Commission and/or OTC Markets. Gold River disclaims any obligation to update or alter its forward-looking statements whether as a result of new information, subsequent events or otherwise.
Investor caution/added risk and uncertainties for investors in companies claiming involvement in COVID-19 initiatives
On April 8, 2020, SEC Chairman, Jay Clayton and William Hinman, the Director of the Division of Corporation Finance, issued a joint public statement on the importance of disclosure during the COVID-19 crisis.
The SEC and Self-Regulatory Organizations are targeting public companies that claim to have products, treatments or other strategies with regard to COVID-19.
The ultimate impact of the COVID-19 pandemic on the Company’s operations is unknown and will depend on future developments, which are highly uncertain and cannot be predicted with confidence, including the duration of the COVID-19 outbreak. Additionally, new information may emerge concerning the severity of the COVID-19 pandemic, and any additional preventative and protective actions that governments, or the Company, may direct, which may result in an extended period of continued business disruption, reduced customer traffic and reduced operations. Any resulting financial impact cannot be reasonably estimated at this time.